Nuclear Medicine Market Size, Share & Industry Analysis, By Type (Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F, 68Ga, 68Cu, 11C, and Others] and SPECT Radiopharmaceuticals [Technetium-99m, Iodine-123, Xenon-133, Thallium-201, and Others]} and Therapeutics {Ra-223, Sm-153, Lu-177, I-131, Y-90, and Others}), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101812

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 19.4% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Type Diagnostics PET Radiopharmaceuticals FDG-PET/18F 68Ga 68Cu 11C Others SPECT Radiopharmaceuticals Technetium-99m Iodine-123 Xenon-133 Thallium-201 Others Therapeutics Ra-223 Sm-153 Lu-177 I-131 Y-90 Others
	By Application Neurology Cardiology Oncology Others
	By End User Hospitals & Clinics Diagnostic Centers Others
	By Region North America (By Type, By Application, By End User, By Country/ Sub-Region) U.S. Canada Europe (By Type, By Application, By End User, By Country/ Sub-Region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Type, By Application, By End User, By Country/ Sub-Region) Japan China India Australia Southeast Asia Rest of the Asia Pacific Latin America (By Type, By Application, By End User, By Country/ Sub-Region) Brazil Mexico Rest of Latin America Middle East & Africa (By Type, By Application, By End User, By Country/ Sub-Region) GCC South Africa Rest of the Middle East & Africa